Our previous work demonstrated that following human cytomegalovirus (HCMV) infection of fibroblasts, there was a protein-protein interaction between the HCMV IE1-72 immediate-early (IE) protein and the cellular p107 protein which resulted in the alleviation of p107-mediated transcriptional repression of E2F-responsive promoters. In a further characterization of this interaction, we now show that IE1-72 binds to the N-terminal portion of p107, not the C-terminal ' pocket ' region that binds E2F-4, and where a number of other viral gene products bind. Additionally, we show that exons 2 and 3 of IE1-72 are required for binding to p107. After mapping the binding domains, we next wanted to address the additional functional consequences of this interaction. It is well known that p107 can negatively regulate cell growth. To examine whether IE1-72 can also overcome this growth suppression, we transfected and infected or cotransfected various constructs into SAOS-2 cells. We showed that infection of SAOS-2 cells was capable of alleviating p107-mediated growth suppression. Additionally, we showed that IE1-72 alone is capable of overcoming p107-mediated growth arrest. Alleviation of this repression by IE1-72 is dependent on the protein-protein interaction between p107 and IE1-72 as deletion mutants of either protein which lack the identified binding domains fail to achieve this effect. These data indicate that the IE1-72 protein is capable of overcoming p107-mediated blocks in cellular proliferation, events that occur in both productive and non-productive HCMV infections.
Introduction
Human cytomegalovirus (HCMV) is associated with severe pathogenesis in immunocompromised individuals, transplant patients and during pregnancy (Huang & Kowalik, 1993) . HCMV is also a leading infectious cause of birth defects. In addition, HCMV has recently been implicated in the aetiology or co-aetiology of several human malignancies, strongly suggesting that HCMV infection can disrupt normal cellular proliferation (Huang & Kowalik, 1993 ; Shen et al., 1993) . Furthermore, recent evidence has implicated HCMV in the abnormal proliferation of smooth muscle cells during restenosis (Speir et al., 1994) and in the stimulation of DNA replication in growth-arrested cells (Speir et al., 1994 ; Jault et al., 1995 ; Poma et al., 1996) , lending additional support to the notion that e-mail eshuang!med.unc.edu HCMV infection can be tied to changes in the cell cycle state of the host cell. Regardless of whether cellular DNA replication occurs following infection, there is ample evidence that HCMV induces the synthesis of the cellular products associated with DNA replication (Huang et al., 1973 ; Estes & Huang, 1977 ; Benson & Huang, 1988 to, at the very least, ' set the stage ' for its own replication and consequently its own survival.
In this and other respects, HCMV is similar to the model DNA tumour viruses [adenovirus, SV-40 and human papillomavirus (HPV)] which induce cell cycle progression in quiescent cells as a means to usurp host DNA replication machinery and facilitate the production of viral progeny (Cherington et al., 1988 ; Kaelin et al., 1990 ; Dyson et al., 1992) . Like the model DNA tumour viruses, HCMV encodes a viral protein capable of binding and altering the transcriptional activities of p53 (Speir et al., 1994) . Similarly, HCMV infection is associated with the accumulation of DNA damage and chromosomal aberrations (Jault et al., 1995) , and the inhibition of apoptosis . In addition, as with the small DNA tumour viruses, HCMV infection has also been tied to changes in E2F-complexes and the targeting of the two pocketproteins, pRb and its family member p107, by virally encoded proteins (Wade et al., 1992 ; Hagemeier et al., 1994 ; Choi et al., 1995 ; Poma et al., 1996) . In the case of HCMV, however, binding of the two pocket-proteins is done through two distinct virally encoded proteins, , that interact exclusively with pRb and p107, respectively, a potentially important difference from the DNA tumour viruses which encode only one viral gene product capable of binding both pRb and p107.
The IE1-72 protein is a nuclearly localized immediate-early (IE) protein. IE1-72 expression has been shown to activate a series of viral and cellular promoters (Sambucetti et al., 1989 ; Hayhurst et al., 1995 ; Margolis et al., 1995 ; Yurochko et al., 1995) . IE1-72 can also transcriptionally synergize with IE2-86, although the mechanisms of this activation are not fully understood (Stenberg, 1993 ; Lukac et al., 1997) . In addition, two recent studies have shown that IE1-72 deletion mutant viruses cannot replicate at low multiplicities of infection (m.o.i.), but can at high m.o.i.s, suggesting that IE1-72 is essential at low m.o.i.s, while apparently at high m.o.i.s other viral products functionally compensate for the lack of IE1-72 (Mocarski et al., 1996 ; Greaves & Mocarski, 1998) . Little else is known about the function of IE1-72, although data from our laboratory on the interaction with p107, as well as results from other laboratories, suggest that its expression influences the cell cycle state of cells by either inducing cellular proliferation or by preventing apoptosis in certain cell types Poma et al., 1996) . p107 comes from a family of cell cycle inhibitors that include its more famous member, pRb (Weinberg, 1991) . pRb plays an important role as a regulator of E2F, a class of heterodimeric transcription factors involved in DNA replication and cellular proliferation (Bagchi et al., 1991 ; Bandara & La Thangue, 1991 ; Chellappan et al., 1991 ; Chittenden et al., 1991) . Because the genes involved in DNA replication (dihydroxyfolate reductase, thymidine kinase, etc.) contain E2F-responsive elements in their promoters, pRb is a powerful negative regulator of S-phase induction and cell cycle progression (Weinberg, 1995) . The HCMV IE2-86 protein can bind pRb in a manner analogous to E1A of adenovirus, large T of SV-40 and E7 of HPV, and can functionally disrupt the ability of pRb to regulate E2F activity (Hagemeier et al., 1994 ; Choi et al., 1995) . p107 shares extensive sequence and functional homology with pRb (Ewen et al., 1991 ; Zhu et al., 1995 b) . Overexpression of p107 can transcriptionally silence E2F-responsive promoters in a manner analogous to that seen with pRb (Schwartz et al., 1993 ; Zhu et al., 1993 .
Complexes containing E2F and p107 have also been shown to be subject to regulation during infection by HCMV and the model DNA tumour viruses (Wade et al., 1992) . Data from our laboratory have shown that p107 protein levels are induced during HCMV infection and that IE1-72 is complexed with p107 from early to late times of infection (Poma et al., 1996) . Our data have also shown that IE1-72 is capable of alleviating p107-, but not pRb-, mediated transcriptional repression of E2F-responsive promoters. Because each E2F family member has different activities on cell cycle progression (Lukas et al., 1996) , the apparent regulation of different E2F regulators by different HCMV IE proteins may be a mechanism to temporally regulate the cellular environment during infection through sequential transcriptional activation of different E2F species.
Here we present data demonstrating that the interaction between p107 and IE1-72, unlike the interaction between p107 and the adenoviral oncoprotein, E1A, does not result in the disassociation of E2F-4 from p107. We also show that the IE1-72 and p107 interaction is dependent on the N terminus of p107 and exons 2 and 3 of IE1-72. In the context of a viral infection, we believe that IE1-72 and IE2-86 act as a team to alleviate p107 and pRb growth suppression, respectively. However, in this paper, we wanted to explore the effect of IE1-72 on p107-mediated growth suppression without the added complexity of the IE2-86-pRb interaction. Therefore, we used SAOS-2 cells, which do not contain wild-type pRb, as a model to study the effect of IE1-72 on cellular growth. Functionally, we demonstrated that infection is capable of overcoming p107-mediated growth suppression and that the viral component responsible for overcoming the p107-mediated suppression is IE1-72. Finally, we demonstrated that the alleviation of repression was dependent on the actual interaction between the two proteins as deletion mutants of exon 3 in the IE1-72 protein or the N-terminal region of the p107 protein failed to alleviate growth repression. The alleviation of p107-mediated growth suppression by IE1-72, we hypothesize, represents an important mechanism by which HCMV can stimulate proliferation or at least a ' proliferative-like or S-phase-like ' state such that the cellular DNA replication machinery necessary for viral DNA replication and consequently the entire virus lifecycle is induced. Though activation of host DNA replication machinery has been well-established with the studied DNA tumour viruses, our data now demonstrate similar but novel pathways involved in the interaction between the HCMV IE1-72 product and p107 to, no doubt, functionally accomplish the same goal.
Methods
Cell culture. The human osteosarcoma SAOS-2 cell line, the human embryonic lung (HEL) fibroblast cell line and the human C33A cervical carcinoma cell line were obtained from ATCC and grown in Eagle's DMEM supplemented with 10 % foetal bovine serum (Gibco BRL) and penicillin-streptomycin at 37 mC in a 6% CO # incubator.
Preparation of cell lysates for Western blot analysis and immunoprecipitation. C33A and SAOS-2 cells were harvested, pelleted and washed twice with PBS. Cells were incubated in EBC buffer [0n05 M Tris-HCl (pH 8n0), 0n12 M NaCl, 0n5 % NP-40, 0n1 M NaF, 0n2 mM sodium orthovanadate, 1 mM PMSF] at 4 mC for 1 h with
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Mapping of the IE1-72-p107 interaction Mapping of the IE1-72-p107 interaction leupeptin and aprotinin added at 10 µg\ml each. Supernatant was removed and protein concentration was determined with the Bio-Rad Protein Assay kit.
Western blot analysis. The p107 polyclonal and monoclonal antibodies were purchased from Santa Cruz Biotechnology and the E1A antibody was purchased from Oncogene Science. The IE protein antibodies were raised to non-conserved domains in the IE1-72 and IE2-86 proteins and have been described previously (Kowalik et al., 1994) . Equal protein amounts of whole cell extract (40 µg) were separated on SDS-PAGE gels and then transferred overnight to Immobilon-P Membranes (Millipore). Blots were blocked in 5 % (w\v) Carnation nonfat dry milk dissolved in PBS-0n1 % Tween 20. Blots were probed with primary antibody in PBS-0n1 % Tween 20 (1 : 400 dilution for p107 and 1 : 1000 for the IE proteins). After extensive washing, blots were probed with an appropriate secondary antibody (Sigma). Blots were again washed extensively and developed by enhanced chemiluminescence (Amersham).
Immunoprecipitations. Equal protein amounts of lysates (200 µg) were precleared with Pansorbin Cells (CalBiochem). The appropriate monoclonal antibody (0n17 µg\100 µl) and Protein G beads (15 µl) (Pharmacia) were added and then incubated in an ELB + buffer [0n25 M NaCl, 0n1 % NP-40, 0n05 M HEPES (pH 7n0), 1 mM PMSF, 5 mM EDTA, 0n5 mM DTT]. The incubations were performed with constant mixing. Beads were then spun down, washed extensively with ELB + buffer, and then separated by SDS-PAGE followed by Western blot analyses. All immunoprecipitation experiments also used preimmune serum as a control. This negative control showed no activity in all cases (data not shown).
Plasmids. The IE1-72 full-length and mutant expression vectors (pSG5IE1, pSG5IE1LZ, pSG5IE1acidic, pSG5IE1exon2\3 and pSG5IE1-exon3) were generous gifts from J. H. Sinclair (Cambridge, UK) and have been described previously (Hayhurst et al., 1995 ; Yurochko et al., 1995 ; Poma et al., 1996) . The p107 expression vectors (pCMVp107 and pBSp107) and the p107 deletion mutant vectors (pCMVN385, pCMVN19 and pCMVL19) have also been described previously (Zhu et al., 1993 . Lastly, the DP-1 (pCMVDP-1), E1A (pGEME1A and pCMVE1A) and E2F-4 (pCMVE2F % ) vectors have been described previously (Hinds et al., 1992 ; Beijersbergen et al., 1995) .
In vitro protein interactions. All labelling of proteins was done using the Promega TT coupled reticulocyte lysate system in the presence of [$&S]methionine. Proteins were translated individually, then mixed in the indicated combinations for 1 h at 30 mC. Immunoprecipitations were performed as described above. Reactions were allowed to proceed overnight and then the beads were washed, followed by separation by SDS-PAGE. Gels were dried and developed by autoradiography. Appropriate negative controls were performed to show that the TT system does not produce an artifact that binds to the antibodies used in our experiments.
Transfections. C33A cells were transfected at 60 % confluency using the Lipofectamine transfection reagent (Gibco BRL) according to the manufacturer's specifications. For deletion mutants analysis, cells were transfected with 3 µg of each expression vector and 1 µg of a β-galactosidase expression construct. Transfection efficiencies were monitored by in situ staining for β-galactosidase. Transfection of the SAOS-2 cell line for immunoprecipitation of E2F-4 and for the proliferation assays was done using the DOSPER liposomal transfection reagent (Boehringer Mannheim) and 4 µg of each indicated plasmid.
Infection of SAOS-2 cells.
SAOS-2 cells were infected at an m.o.i. of 2-3 (Poma et al., 1996) . After 24 h, plates were harvested and lysate prepared. Western blot analyses for IE1-72 and IE2-86 were performed. For the transfection\infection experiments, cells were first transfected and then infected 24 h after transfection. The proliferation assay was performed 24 h after infection using Promega CellTitre 96 system. Cell proliferation assay. SAOS-2 cells were transfected as described above ; 24 h after transfection, the Promega CellTitre 96 system was used to determine cellular proliferation following transfection. The Promega CellTitre 96 system is based on conversion of tetrazolium salt into a formazan product by the action of cellular NADHgenerating dehydrogenases, enzymes that are metabolically active only during cell proliferation ; in direct comparisons, this assay has been shown to have a less than 5 % difference in final results as compared to the standard [$H]thymidine incorporation assays. All proliferation assays were done in triplicate and repeated a minimum of three times. The standard deviation in percentage of cells proliferating is reported. All absorbance readings were done in the linear range at 570 nm. The values for percentage cells proliferating, as described in Tables 1-4 , represent the percentage of cells proliferating in each of the tested\transfected cases as compared to the number of cells proliferating in the vector alone transfected control (set to 100 %).
Data and statistical analysis. All autoradiographs were image captured using NIH image capturing software and then labelled and printed using MacDraw Pro and an Apple computer. Statistical significance of experimental results was analysed using the two-sample ttest by the Biostatistics Core Facility of the Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill. A P value of less than 0n05 was considered significant.
Results
The HCMV IE1-72 protein binds to p107 in a novel region of the p107 molecule
The pocket region of p107 is the selected site for cellular and viral products to bind [i.e. E2F and adenoviral E1A, respectively Ikeda & Nevins, 1993) ]. To initially examine if IE1-72 binds p107 like E1A, we examined if E1A could similarly displace IE1-72 associated with p107 or if they both bound, suggesting the use of a different binding region. In lane 6 of Fig. 1 (A) , the IE1-72 protein and the p107 protein were in vitro translated, mixed, and then co-precipitated with antibody to p107. In lane 7 of Fig. 1 (A) , in vitro translated adenovirus E1A protein was added to translated IE1-72 and p107, and p107 was again immunoprecipitated. As can be seen, both the adenovirus E1A protein and the HCMV IE1-72 protein co-precipitated with the p107 protein ; the equivalent amounts of IE1-72 protein co-precipitating in lanes 6 and 7 indicate that the presence of E1A protein did not compete with the IE1-72 protein for binding to p107, demonstrating that they must bind to different regions of the p107 molecule. Lanes 4 and 5 represent negative controls which show that, in accordance with previously published results, pRb can immunoprecipitate E1A, but not IE1-72 (Poma et al., 1996) . In addition, we also showed that anti-IE1-72 antibodies did not immunoprecipitate E1A and that anti-E1A antibodies did not immunoprecipitate IE1-72 (data not shown). Fig. 1 (B) represents the direct loads of IE1-72, p107 and E1A in vitro translated proteins, respectively. As Fig. 1 (A) suggests, IE1-72 binds p107 outside of the C-terminal pocket region. These data would also imply that IE1-72 does not displace E2F bound to the pocket region of p107. To verify this, we transfected SAOS-2 cells with expression vectors for p107, E2F-4 and DP-1 (the E2F-4 binding partner) and, additionally, either the vector for IE1-72 or E1A. Harvested cell lysates were then immunoprecipitated with an E2F-4 antibody. Subsequently, Western blot analysis for the p107 protein was performed (Fig.  1 C) . As can be seen in lane 1, immunoprecipitation of E2F-4 demonstrates that, as has been reported previously, the p107 protein co-precipitates with the E2F-4 protein (Beijersbergen et al., 1994 ; Ginsberg et al., 1994) . Expected results are also shown in lane 3 in which E1A, a protein known to disrupt the interaction of p107 and E2F-4, prevents the co-precipitation of E2F-4 and p107 (Zamanian & La Thangue, 1993) . Expression of the IE1-72 protein, however, does not have the same effect (compare lanes 2 and 3). Although somewhat lower levels of p107 protein are co-precipitated with E2F-4 in the IE1-72-transfected cells as compared to the samples without IE1-72 (the empty vector-transfected cells, compare lanes 1 and 2), the results are not as drastic as the complete disassociation between E2F-4 and p107 seen in the E1A-transfected cells. In this representative experiment, five times the amount of IE1-72 expression vector as E1A expression vector was transfected into these cells, underscoring the relative lack of disassociation between E2F-4 and p107 in the IE1-72 transfected cells. Control Western blot analysis for the p107, E2F-4, IE1-72 and E1A proteins used in Fig. 1 (C) are shown in Fig. 1 (D) .
IE1-72 binding to p107 requires the N terminus of p107
To determine the exact region of p107 necessary for interaction with the IE1-72 protein, we overexpressed IE1-72 and full-length or deletion mutants of the p107 protein (see
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Mapping of the IE1-72-p107 interaction Mapping of the IE1-72-p107 interaction Fig. 2 A) in C33A cells. Lysates of the transfected cells were prepared and IE1-72 was immunoprecipitated from these lysates. IE1-72 precipitates were then analysed for the presence of full-length or deletion mutants of p107 by Western blot analysis using an anti-p107 antibody. In lanes 1 and 2 (Fig.  2 B) , cells were transfected with either the control vector pCDNA3 (lane 1) or the IE1-72 expression vector (lane 2). In lanes 3 and 5, cells were transfected with the IE1-72 expression vector and either the full-length p107 expression vector (lane 3) or the L19 deletion mutant vector, a C-terminal truncation of the protein that fails to bind E2F (lane 5) ; immunoprecipitation of the IE1-72 protein from these cells resulted in the coprecipitation of both the full-length and the L19 deletion mutant of p107. In lanes 4 and 6, cells were again transfected with the IE1-72 expression vector and either the N19, an Nand C-terminal deletion of the protein that fails to bind E2F and cyclins A or E, or the N385, an N-terminal deletion of the protein that fails to bind cyclins A or E, expression vectors. Neither the N19 nor the N385 deletion mutant was found complexed with IE1-72 (lanes 4 and 6), demonstrating that the N terminus of p107 is required for its interaction with IE1-72. In addition, we also showed that N19 and N385 were viable proteins and could be immunoprecipitated and detected by Western blot analysis with an anti-p107 antibody (data not shown). Control Western blot analyses of the cell lysates used in Fig. 2 (B) are shown in Fig. 2 (C) .
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Interaction between IE1-72 and p107 is dependent on exons 2 and 3
We have previously described the protein-protein interaction between p107 and the HCMV-encoded IE1-72 protein in the context of HCMV infection of fibroblasts or in vitro interactions (Poma et al., 1996) . Here, we have concentrated on further characterizing this interaction by mapping the domains in each protein necessary for binding (see map in Fig. 3 C) . p107 and full-length or various deletion mutants of IE1-72 were co-expressed in an in vitro translation system and then immunoprecipitated with antibodies recognizing p107. As we have reported previously, full-length IE1-72 coprecipitates with p107 ( Fig. 3 A, lane 1) . In lane 4 of Fig. 3 (A) , immunoprecipitation of p107 with the anti-p107 antibody detected the IE1-72 deletion mutant 3, the IE1-72 protein lacking the zinc-finger domain (see Fig. 3 C) . In lane 5, immunoprecipitation resulted in co-precipitation of p107 and deletion mutant 4 of IE1-72, a deletion of the acidic region. Lanes 2 and 3, however, clearly show that deletions of exons 2 and 3 (deletion mutant 1) or deletion of exon 3 alone (deletion mutant 2) abolished interaction with p107, demonstrating that a region in exon 3 of IE1-72 is crucial for the interaction with 107. As can be seen in Fig. 3 (A) , roughly equivalent amounts of the cellular p107 protein were precipitated in all lanes. Fig. 3 (B) is a direct load of full-length IE1-72 and the deletion mutants used in Fig. 3 (A) .
HCMV infection of SAOS-2 cells is non-productive but results in IE gene expression
We wished to determine whether SAOS-2 cells could be successfully infected by HCMV because this cell type is the model cell type used for studying p107 function since it does not contain wild-type pRb (Zhu et al., 1993) . SAOS-2 cells were infected at an m.o.i. of 2-3 and 24 h after infection cells were harvested and Western blot analyses performed for the presence of the IE proteins (Fig. 4) . HCMV-infected SAOS-2 cells expressed both IE proteins (lane 2). In contrast, cells that were mock-infected (lane 1) or infected with UV-irradiated Table 1 . HCMV infection alleviates p107-mediated growth suppression SAOS-2 cells were transfected at 60 % confluency with the various constructs (pCDNA, the control vector ; pCMVp107, p107) and then infected as described in Methods. Percentage of cells proliferating is described in the text and was measured using the Promega CellTiter kit ; numbers represent the percentage of cells proliferating in each of the tested\transfected cases as compared to the number of cells proliferating in the vector alone transfected-control. [$H]Thymidine incorporation measurements and flow cytometry cell cycle analysis were also performed to confirm cellular proliferation.
Plasmid(s) transfected pCDNA3 p107 pCDNAjHCMV p107jHCMV
Percentage of cells proliferating 100p5n5 63p4n0 9 9 p9n6 9 4 p2n5 HCMV (lane 3) did not express the HCMV IE genes. Although IE gene expression was detected (by immunoperoxidase staining we showed that 97 % of the cells expressed the IE gene products), the infection was not productive and viral progeny were not released (data not shown). Lysate from 24 h infected HEL fibroblasts was run as a positive control (lane 4).
HCMV infection and IE1-72 alleviates p107-mediated growth suppression
It has been reported previously that overexpression of p107 can suppress cellular proliferation (Zhu et al., 1993 ). Because we have previously shown that IE1-72 can interact and overcome p107-mediated repression of E2F promoter activity, we wished to now determine whether virus (Table 1) or IE1-72 (Table 2) could alleviate p107-mediated growth suppression. As mentioned above, we chose to use SAOS-2 cells in our studies because : (i) they are the published model cell type for studying p107-mediated effects (Zhu et al., 1993) ; (ii) they can be infected and express and (iii) BCJI Table 2 . IE1-72 is capable of alleviating p107-mediated growth suppression SAOS-2 cells were transfected at 60 % confluencey with either (1) vector alone (pCDNA3), (2) an IE1-72 expression vector, pCDNA3-IE1-72, (3) an IE2-86 expression vector, pCDNA3-IE2-86, (4) the p107 expression vector pCMVp107, (5) the N19 deletion mutant of p107 (an N-and C-terminal deletion mutant, (6) the IE1-72 and p107 expression vectors, (7) the IE2-86 and p107 expression vectors, or (8) the p107 and CD20 expression vectors. Percentage of cells proliferating is described in the text ; the numbers represent the percentage of cells proliferating in each of the tested\transfected cases as compared to the number of cells proliferating in the vector alone transfected-control (set to 100 %). [$H]Thymidine incorporation measurements and flow cytometry cell cycle analysis were also performed to confirm cellular proliferation.
Plasmid(s) transfected pCDNA3 IE1-72 IE2-86 p107 N19 p107jIE1-72 p107jIE2-86 p107jCD20
Percentage of cells proliferating 100n0p5n7 89n2p7n3 91n5p10n2 58n0p10n8 98n1p5n1 9 0 n0p6n4 6 3 n2p2n0 5 5 n0p7n1 they, unlike fibroblasts, contain no wild-type pRb to interfere with the examination of the effect of IE1-72 on 107 function. Therefore, we transfected SAOS-2 cells with an empty vector (pCDNA3) or a p107 expression vector (pCDNA3-p107), infected them and then determined their proliferation status.
As can be seen in Table 1 , p107 expression resulted in an approximately 35-40 % drop in the number of cells proliferating as compared to the vector-alone expressing cells (P 0n01), matching the results previously reported for growth suppression by p107 in SAOS-2 cells. By contrast, approximately 90 % of the p107-transfected\infected cells were proliferating. These data demonstrate that HCMV can alleviate p107-mediated growth repression. We next wanted to determine if IE1-72 could overcome this p107-mediated growth suppression. In Table 2 , SAOS-2 cells were transfected with equivalent amounts of the vector alone, an IE1-72 expression vector, an IE2-86 expression vector, a p107 expression vector, the N19 [an N-terminal deletion mutant (see Fig.  2 A)] expression vector, co-expression of the IE1-72-and p107-expressing vectors, co-expression of the IE2-86-and p107-expressing vectors, or co-expression of the CD20-and p107-expressing vectors (a negative control for alleviation of repression). Expression of IE1-72 or IE2-86 alone resulted in a slightly lower level of proliferation as compared to cells transfected with the empty vector. Expression of the p107 protein in these experiments, however, resulted in a more than 40 % drop in the number of cells proliferating while expression of the N19 deletion mutant of p107 did not repress cell growth, as has been reported previously (Zhu et al., 1995 b) . However, when IE1-72 was added along with p107, cellular proliferation returned to 90 % of vector-alone levels, demonstrating the ability of IE1-72 to overcome p107-mediated growth suppression. As expected, IE2-86 did not affect p107-mediated growth suppression. In addition, to confirm that our proliferation assays are functionally competent to measure cellular proliferation, we also examined, under the same conditions as described above, cellular proliferation by [$H]thymidine incorporation and flow cytometry (data not shown). In all cases measured, p107 decreased proliferation and HCMV and IE1-72 alleviated the p107 block in proliferation.
Deletion mutants of IE1-72 that lack exons 2 and 3 fail to alleviate p107-mediated growth suppression
Because data from Fig. 3 indicated that exons 2 and 3 of IE1-72 were necessary for the interaction with p107, we next wished to determine if exons 2 and 3 were also necessary for alleviation of growth suppression (Table 3) . Co-transfection of SAOS-2 cells with expression vectors of deletion mutant 3 or deletion mutant 4 (see Fig. 3 C) , both of which contain exons 2 and 3, successfully overcame p107-mediated growth arrest (P 0n001 and 0n01). Deletion mutants 1 and 2 (the IE1-72 protein with either exons 2 and 3 or exon 3 alone deleted, respectively), however, failed to alleviate p107-mediated growth suppression (P 0n50 for both), demonstrating that exons 2 and 3 are not only required for the interaction of IE1-72 with p107 but also are required for the alleviation of p107-mediated growth suppression. Expression of deletion mutant 1 resulted in a slight reduction in cellular proliferation. We have noticed mild toxicity associated with expression of some of the IE1-72 expression constructs (data not shown).
Expression of IE1-72 is capable of alleviating L19-mediated but not N385-mediated growth suppression
It has been reported previously that p107 contains two distinct domains that can both independently suppress growth in SAOS-2 cells. The L19 mutant contains amino acids 1-781 of the N terminus of p107 and lacks a functional pocket ; growth suppression by this deletion mutant has been shown to occur through an E2F-independent mechanism (Zhu et al., 1995 b) . The N385 deletion construct encompasses amino acids 385-1068 of the protein ; growth suppression by this deletion mutant has been correlated to the E2F-binding activity of the protein (Zhu et al., 1995 b) . As our data from Fig. 2 demonstrate, the IE1-72 protein is capable of interacting only with the L19 Table 3 . Exons 2 and 3 of the IE1-72 protein are required for alleviation of p107-mediated growth suppression SAOS-2 cells were transfected at 60 % confluency with the described IE1-72 deletion mutants with or without a p107 expression vector. Levels of proliferaton for cells transfected with the IE1-72 deletion mutants lacking both exons 2 and 3 (deletion 1) or only exon 3 (deletion 2) and with or without an expression vector for p107 are described above. In addition, levels of proliferation for cells transfected with the IE1-72 deletion mutants lacking the zinc-finger domain (deletion 3) or the acidic region of the protein (deletion 4) with or without an expression vector for the p107 are shown in the last two columns, respectively. Percentages of cells proliferating represent the number of cells proliferating in each of the transfected cases as compared to the number of cells proliferating in the vector alone-transfected control.
Plasmid ( 
Percentage of cells proliferating 100n0p4n5 9 5 n7p0n4 6 9 n4p1n7 9 6 n8p3n3 6 3 n1p4n3 6 7 n2p2n8 mutant and fails to bind the N385 mutant of p107. SAOS-2 cells were growth suppressed by transient transfection with the L19 deletion mutant (Table 4 ; P 0n001), and subsequent co-expression of the IE1-72 protein with the L19 deletion mutant alleviated this growth suppression (P 0n001). Growth suppression was also obtained with transient transfection of the N385 deletion mutant (P 0n001), but cotransfection of the IE1-72 protein with the N385 deletion mutant failed to alleviate N385-mediated growth suppression in the SAOS-2 cell line (P l 0n068). As with the results presented in Table 3 , these data demonstrate that the same regions of the proteins that are necessary for the proteinprotein interaction to occur are also necessary for the biological effect of alleviation of growth suppression.
Discussion
Previous data from our laboratory have shown that, during infection of fibroblasts, the HCMV IE1-72 gene product, but not the IE2-86 gene product, could be found complexed with p107 (Poma et al., 1996) . Furthermore, we demonstrated that binding of IE1-72 to p107 was specific and did not extend to an interaction with the closely related pRb protein. We also showed that expression of IE1-72 was capable of alleviating p107-mediated transcriptional repression of E2F-responsive promoters, but not pRb-mediated transcriptional repression. The HCMV IE2-86 protein, however, had been shown to bind pRb and inactivate pRb-mediated repression (Hagemeier et al., 1994 ; Choi et al., 1995) . This use of two distinct proteins for the inactivation of the different pocket proteins was surprising because of the paradigm that has been established with the DNA tumour viruses in which only one virally encoded protein (E1A of adenovirus, E7 of HPV and large T of SV-40) binds to and alleviates transcriptional repression by all members of the pocket-protein family. These differences suggest that HCMV might have a vested interest in temporally and subtly regulating the various E2F species which interact with the different pocket proteins in an orderly manner to prevent the aberrant infections and cellular transformations that are often seen with the DNA tumour viruses.
We wished to continue our investigation of the interaction of IE1-72 with p107 by first mapping the domains responsible BDAA for the interaction between these two proteins. As demonstrated, we showed that IE1-72 binds to the N terminus of p107, not the C terminus where the pocket region is and where E1A and E2F-4 are reported to bind. The data demonstrating the unique binding of IE1-72 to the N-terminal region of p107, a region that does not share homology to pRb, make it logical that IE1-72 only binds p107. Further support for this unique binding comes from analysing how the other identified viral gene products (E1A, large T and E7) have been documented to bind to the pocket proteins. All of these viral proteins have been shown to encode an LXCXE amino acid motif that recognizes the conserved E2F-binding region of the pocket proteins and facilitates binding (Dyson et al., 1989 ; Kaelin et al., 1990) . This consensus LXCXE motif cannot be found in exons 2-4. This lack of a known binding motif again underscores the subtle but potentially important differences between the interaction of the HCMV IE products with the E2F-regulating pocket proteins and the model that has been established with the products of the small DNA tumour viruses. In addition, we noticed that expression of IE1-72 did not result in high levels of disassociation of E2F-4 from p107 as was seen with E1A. Even though IE1-72 does not completely dissociate E2F-4 from p107, binding of IE1-72 still overcomes the repressive effect of p107. It is still unclear how the alleviation of p107-mediated transcriptional repression by IE1-72 occurs and we are currently pursuing this goal. Phosphorylation might be involved as a mechanism for the alleviating effect of E1-72 on p107 because of the recent evidence that IE1-72 can phosphorylate p107 and not pRb (Pajovic et al., 1997) .
In mapping the region of IE1-72 that binds p107, we demonstrated that exons 2 and 3 were responsible for the interaction of IE1-72 with p107. Because exons 2 and 3 are shared between IE1-72 and IE2-86, it could be argued that IE2-86 should also similarly interact with p107. However, data from our laboratory have previously shown conclusively that the IE2-86 protein does not bind p107 or alleviate p107-mediated repression of E2F-responsive promoters (Poma et al., 1996) , nor as presented in Table 2 does it relieve p107-mediated growth suppression. Thus, although exons 2 and 3 are necessary for the interaction of IE1-72 with p107, it alone is not sufficient for this interaction to occur. We hypothesize that : (i) the domain of interaction on the IE1-72 protein may extend into exon 4, a region unique to IE1-72, providing an IE1-72-dependent nature to this interaction ; or (ii) that exon 4 may provide a conformational change in exons 2 and 3 (making the three-dimensional structure of exons 2 and 3 unique compared to that of IE2-86), which again would allow for a unique IE1-72-dependent interaction with p107.
Since p107 has been shown to act as a negative regulator of cellular proliferation (Zhu et al., 1993 and because infection by HCMV has been shown to be capable of activating cellular DNA replication machinery and driving growtharrested cells to enter an S-phase-like environment, we have chosen to investigate whether expression of IE1-72 can overcome p107-mediated cellular growth arrest. SAOS-2 cells are the model cell line of choice for examining p107 growthsuppressive effects. In addition, because they are derived from a cell type that has been shown clinically to be infected by HCMV, we inferred that we could also infect these cells. Finally, using this cell type allowed us to focus on the p107-IE1-72 effect on growth suppression without the interference of the pRb-mediated effects. We first demonstrated that HCMV infection could overcome p107-mediated growth suppression and then that the viral component responsible for mediating this activity in SAOS-2 cells was IE1-72. Alleviation of p107-mediated growth suppression occurs only with deletion mutants of IE1-72 that contain exon 3, demonstrating that actual binding of p107 by IE1-72 is necessary to achieve this effect. It should be noted that we confirmed the nature of our proliferation assays with standard [$H]thymidine incorporation and flow cytometric assays which in all cases tested supported the results of the proliferation assays (data not shown).
Two recent studies using an IE1-72 deletion mutant virus support our hypothesis of the vital role IE1-72 plays in the virus life-cycle (Mocarski et al., 1996 ; Greaves & Mocarski, 1998) . The authors showed that at the low m.o.i.s we used in our experiments, these mutant viruses were unable to replicate, tantalisingly suggesting that IE1-72's effect on cellular regulation is necessary for the virus life-cycle. Although their results do not demonstrate that the lack of virus replication is due to an inability to regulate the intracellular state of the cell, their results do not discount this possibility. We have recently acquired this virus and will in the future test it out in our system.
Further support for the importance of the functional interaction of IE1-72 with p107 comes from the reverse studies in which we used full-length IE1-72 and the various p107 mutants to examine which combination can alleviate growth suppression. We found that growth suppression of SAOS-2 cells following N385 overexpression (the N-terminal mutant) could not be alleviated by co-expression of the IE1-72 protein. This is not surprising in the light of our data showing that IE1-72 is incapable of binding the N385 deletion mutant, because the deleted region is required for the p107-IE1-72 interaction. This N385 mutant has previously been shown to growth suppress SAOS-2 cells in an E2F-dependent manner. However, it should be noted that the IE1-72 protein can interact with fulllength p107 to functionally activate E2F-mediated transcription, suggesting that alleviation of full-length p107-mediated growth suppression by the IE1-72 protein may involve an E2F-dependent pathway. The IE1-72 protein is capable, however, of overcoming L19-mediated (the C-terminal mutant) growth suppression. Again, this correlates directly with our data, in which we demonstrated that the IE1-72 protein was capable of complexing with the L19 deletion mutant. The mechanism behind the growth suppression by the L19 domain of p107 is not as well understood. The third E2F-regulating target of viral DNA tumour viruses is p130. We have been unable to detect an interaction between IE1-72 and p130.
Our data fit our model and the data of others in which HCMV infection of quiescent cells creates an S-phase-like environment that allows for viral DNA replication to occur through specific targeting of the pocket-protein family members by different viral IE gene products. This model is best illustrated by the results reported here in which IE1-72 can overcome the ability of p107 to growth suppress cells. Furthermore, there is clinical evidence that infection (at least non-productive) may lead to abnormal cellular proliferation (Speir et al., 1994) . Although it is controversial as to whether HCMV infection induces cellular DNA synthesis, it is clear that the DNA replication machinery is turned on as a result of HCMV infection. We believe that our data represent one of the mechanism(s) by which this occurs. We feel that we have uncovered a novel function for the HCMV IE1-72 gene product and that it plays an important role in regulating the appropriate intracellular environment necessary for virus replication to take place.
